Graduated from the Department of Clinical Medicine, Wuhan University
16 years of experience, led several projects of anti-tumor macromolecule drugs in comprehensive chain system, from establishment to product launch.
Graduated from the Department of Economics, Shanghai University of Finance and Economics. Abundant experience for over 20 years in the field of biomedicine and information science. In charge of information technique for companies including Sanofi-Aventis, ThyssenKrupp, Shanghai Pharmaceutical Co.,Ltd., CP Guojian Pharm, 3SBio Inc., Shanghai Kehua Bio-Engineering Co.,Ltd. in succession.
Undergraduate of Fudan University, Doctor of Chinese Academy of Sciences
Conducted the developing strategy of 10 kinds of medicines, clinical program design and the medical support of clinical research progress in recent 7 years. Has primary experience and profound knowledge to basic research and medicine development chain.
In charge of the investigation and research of several anti-tumor drugs, and establishment of medical strategy. Expert in preclinical drug action mechanism and Pharmacokinetics, established clinical research strategy, wrote clinical trial plan, established clinical research strategy for non-tumor field, such as Vaccines, Neurology and Endocrinology and wrote plans. Participated in several registered clinical research for new drugs, including Pre-IND to clinical projects stage 1, 2, 3. Most of them are tumor targeted drugs and vaccines for COVID-19.
Over 12 years of experience on clinical trial: worked in renowned international CROs including IQVIA、ICON and INC; possessed project management and operation experience in domestic CRO.
Graduated from clinical pharmacy of Xuzhou Medical University, with more than 10 years of clinical trial experience and more than 4 years of project management experience, he has worked with many large CRO enterprises.
Over 14 years of data management experience, over 7 years of team management experience, led the data team to provide a comprehensive platform management service of clinical data.
Graduated from Southwestern University of Finance and Economics
Worked in IT industry for 20 years, possessed in business IT planning, business process optimizing, system design and development, and concrete practice in IT transforming projects.
Dr. of East China Normal University and Shanghai Jiaotong University, with 10 years of experience in biological sample analysis and pharmacokinetic / pharmacodynamic research, many years of practical experience in new drug R & D and rich management experience of large listed pharmaceutical companies, familiar with and involved in all key links of pharmaceutical R & D, and has cross platform and interdisciplinary R & D ability.
Engaged in clinical research SMO management for nearly 10 years, participated in the entrepreneurship and growth of many SMO companies, and was responsible for Department building, establishment of regulations, personnel recruitment, team building, business training, project management, business development and internal and external coordination. Participated in the bidding and implementation of phase I - IV drug clinical research, device clinical research, etc.
More than 12 years of clinical research industry experience, many years of management experience, she has served as a manager and other positions in several MNC pharmaceutical firms.
PhD, researcher of level III of professional technology，before she retired who served as the deputy director of Jiangsu Institute of family planning science and technology，now she is a part-time tutor of master of public administration in school of Humanities of Southeast University. She has long been concerned about the scientific norms and ethical issues in drug safety and clinical research of new drugs. She is vice chairman of the ethics committee of her unit, member of the Expert Advisory Committee on drug safety and risk management of the drug registration review expert advisory committee of the national drug review center, and editorial board member of progress in pharmacy, she is also a member of the ethics Expert Committee of stem cell clinical research in Jiangsu Province, and a member of the ethics committee of several clinical research institutions in Jiangsu Province.
The professor, since 2001, he has been the director of the imaging department of the 81st Hospital of the Chinese PLA. In 2005, he has been the chief physician of the imaging department of the 81st Hospital of the Chinese PLA, professor and master supervisor of Anhui Medical University. Since 2003 Professor Wu have made the cooperation with Internal Medicine-Oncology, and participated deeply clinical trail，at the same time he has served as the member of IEC.
Unionlab' team is distributed in more than 10 cities in the country covering domestic clinical trial center, provides clinical service with quickly responding, high quality and efficiency.
Most members in Unionlab possessed project experience for over 5 years. More than 90% of them have bachelor degrees or above. More than 30% of them graduate from 985/211 schools.
The core team of Unionlab handles carious specialty including medicine, operation, radiography and information. It provides reliable support in integrated delivery.